The ironic thing is the sheer drop in price is probably due in part to the P2P route taking over. It's a more involved process than Sudafed meth, but it's easier to scale, since you aren't bottlenecked by the pharmaceutical supply.

Once you establish the facility and pipeline, you can crank out industrial amounts of crank. The precursors are cheap and used in huge quantities by legitimate labs.